You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

Don't Miss Neurotrophic Keratitis: New Approaches to Assess and Treat

  • Authors: Christopher E. Starr, MD; Zaina Al-Mohtaseb, MD; Sumit Garg, MD
  • CME / ABIM MOC Released: 1/8/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 1/8/2022
Start Activity


Target Audience and Goal Statement

This activity is intended for ophthalmologists, primary care physicians, diabetologists, and endocrinologists.

The goal of this activity is to improve clinicians’ ability to detect and diagnose neurotrophic keratitis (NK) in at-risk populations and aid in the adoption of new targeted treatment options into clinical practice.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Detection, diagnosis, and staging of NK
    • New and emerging therapies for NK
  • Have greater competence related to
    • Selecting the best treatment regimen for NK


Disclosures

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Faculty

  • Christopher E. Starr, MD

    Associate Professor of Ophthalmology
    Director, Refractive Surgery
    Director, Ophthalmic Education
    Weill Cornell Medicine
    New York-Presbyterian Hospital
    New York, New York

    Disclosures

    Disclosure: Christopher E. Starr, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Allergan; Blephex; Bruder; Dompe; Eyevance; Johnson & Johnson; Kala; Novartis; Oculis; Quidel; Spark; Sun; TearLab; Verily
    Owns stock, stock options, or bonds from: Essiri Labs

  • Zaina Al-Mohtaseb, MD

    Associate Professor of Ophthalmology
    Associate Residency Program Director
    Cornea, Cataract & Refractive Surgery
    Baylor College of Medicine
    Houston, Texas

    Disclosures

    Disclosure: Zaina Al-Mohtaseb, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Alcon; Bausch & Lomb; CorneaGen; Ocular Therpeutix; Zeiss
    Received grants for clinical research from: Johnson & Johnson

  • Sumit Garg, MD

    Associate Professor of Ophthalmology
    Cataract, External Disease/Corneal Surgery & Refractive Surgery
    Vice Chair of Clinical Ophthalmology
    School of Medicine
    University of California
    Irvine, California

    Disclosures

    Disclosure: Sumit Garg, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Aerie; Alcon; Allergan; CorneaGen; Dompe; Eyepoint; Glaukos; Ivantis; Johnson & Johnson Vision; Kala; LensGen; Novartis; Samsara Vision; SightSciences; Spyglass; Tarsus; Verana Health; Zeiss
    Owns stock, stock options, or bonds from: LensGen; Spyglass; Tarsus

Editors

  • Kathryn Merlo

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Kathryn Merlo has disclosed no relevant financial relationships.

  • Christina T. Loguidice

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Christina T. Loguidice has disclosed no relevant financial relationships.

  • Yoji Yamaguchi, MA

    Associate Scientific Content Manager, Medscape, LLC

    Disclosures

    Disclosure: Yoji Yamaguchi, MA, has disclosed no relevant financial relationships.

CME Reviewer

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Alimera; Allergan; Genentech; Thea; Zeiss


Accreditation Statements



In support of improving patient care, Medscape LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

Don't Miss Neurotrophic Keratitis: New Approaches to Assess and Treat

Authors: Christopher E. Starr, MD; Zaina Al-Mohtaseb, MD; Sumit Garg, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CME / ABIM MOC Released: 1/8/2021

Valid for credit through: 1/8/2022

processing....

Educational Impact Challenge

 

The goal of this activity is to improve clinicians’ ability to detect and diagnose neurotrophic keratitis (NK) in at-risk populations and aid in the adoption of new targeted treatment options into clinical practice.

Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

  • Print